Transforming Indian Pharma
Innovation, Collaboration, and Sustainability
March 19, 2026 | New DelhiOffer
₹30,000 ₹25,000
Offer valid till 22nd
December, 2025
An initiative by
Overview
With India aiming for a $30–35 trillion economy by 2047, the pharmaceutical industry is a critical growth driver. Currently the fifth-largest contributor to India’s manufacturing GVA, it generates a trade surplus and supports livelihoods, supplying nearly 20% of global generic medicines. Yet, from a value perspective, India still trails globally, highlighting the need to move from volume-based generics to high-value products like biosimilars and innovative therapies.
Read More..Key trends shaping this growth include supply chain resilience, stronger R&D and quality standards, regulatory harmonization, digital and AI adoption, and sustainability. By following the “QuRATE” framework -- Quality, Regulation, Access, Talent, and Entrepreneurial innovation, and targeting specialty generics, APIs, vaccines, and biosimilars, India can grow exports reportedly up to $350 billion by 2047. Public-private collaboration will also be essential to secure India’s position among the top global pharma exporters.
Against this backdrop, the FE Pharma Summit & Awards - 3rd Edition will serve as a platform to help shape India’s pharmaceutical future. The summit will bring together policymakers, industry heads, researchers, and investors driving India’s evolution from a generics powerhouse to a value-driven global pharma leader. The Pharma Awards will celebrate and honor organizations and individuals whose innovation, leadership, and impact are setting new benchmarks in the sector. Join us as we honour the leaders and trailblazers shaping the future of Indian pharma.
Discussion points
01
Strengthening Regulatory & Quality Standards
02
Innovation Beyond Generics
03
Digital Transformation & AI in Pharma
04
Sustainability & Green Pharma Practices
05
India’s Position in Global Pharma Value Chain
06
Intellectual Property & Patent Challenges
Who should attend
Pharma CXOs & Leaders
Policymakers
R&D and Drug Development Leaders
Manufacturing Facility, & API Heads
Supply Chain, Procurement, & Logistics Leaders
Pharma, Technology and Digital Leaders
Packaging, Labelling, & Risk Solutions Experts
Hospital & Healthcare Administration LeadersWhy should you attend
Gain Strategic Insights
Learn from industry leaders, policymakers, and innovators about current trends, challenges, and growth opportunities shaping India’s pharma sector
Explore Innovation and Technology
Discover the latest advances in drug development, biologics, digital transformation, AI, and supply chain solutions
Build Valuable Connection
Network with top executives, regulators, R&D heads, investors, and technology providers to foster collaborations and partnerships
Celebrate Excellence
Participate in the Pharma Awards 2026, honoring organizations and individuals driving innovation, leadership, and impact in India’s pharma industry
Why Partner
- Showcase Your Leadership
Gain unmatched visibility among CEOs, policymakers, and industry innovators.
- Share Your Expertise
Take the stage in panels or sessions to position your company as a thought leader.
- Connect with Key Decision-Makers
Build relationships that drive business growth and strategic partnerships.
- Maximize Brand Impact
Amplify your presence with media coverage, on-site branding, and event promotions.
Glimpses of Previous Edition
photo gallery
Past Speakers
Dr. Ramesh Hariharan
CEO,
Strand Life Sciences
Ramesh Juneja
Chairman & Whole- Time Director,
Mankind Pharma
Dr Shirshendu Mukherjee
Managing Director,
Wadhwani Innovation Network,
Wadhwani Foundation
Dr Suneela Garg
Prof. of Excellence,
Chair Programme Advisory Committee,
NIHFW21- 2025
Anil Pareek
President Medical Affairs & Clinical Research
Ipca Labs
Chaitanya Raju
Chief of AI
HealthPlix
Dilip Shanghvi
Managing Director
Sun Pharma
D R Gahane
Joint Commissioner
Food and Drug Administration
Government of Maharastra
Farhat Umar
President-Global Human Resources
MANKIND PHARMA LTD
Glenn Saldanha
Chairman & Managing Director
Glenmark Pharmaceuticals
Hemant G Koshia
Commissioner, Food and Drug Control Administration
Government of Gujarat
Jaby Jacob
Senior President - R&D,
Bharat Serums and Vaccines
Jaspreet Singh
Partner & National Leader – Client and Markets (Technology and Transformation), Grant Thornton Bharat LLP
Kalyan Mangalapalli
Director
NASSCOM Centre of Excellence IoT & AI , Healthcare
Kiran Mazumdar Shaw
Founder
Biocon Limited
Krishna Prasad Chigurupati
Chairman and Managing Director
Granules India
Krishna Sai T
Associate Vice President IT
Biocon
Madhukar Gangadi
CEO
Medplus India
Nikhil Chopra
CEO
JB Chemicals
P Jayakumar
CEO
Apollo Pharmacy
Pankaj Patel
Chairman
Zydus Group
Prateek Verma
Vice President and
Head ePharmacy
Tata 1mg
Dr Ramaiah Muthyala
President & CEO
Indian Organization for Rare Diseases
Rehan A Khan
Managing Director, India Region
MSD
S Aparna
Secretary
Government of India
Dr. S.Eswara Reddy
Joint Drugs Controller (India)
Central Drugs Standard Control Organization
Dr. Satyanarayana Chava
Founder and CEO
Laurus Labs
Shirish G Belapure
Senior Technical Advisor
Indian Pharmaceutical Alliance
Sridhar Bharadwaj
Vice President Human Resources
J.B. Chemicals & Pharmaceuticals Limited
Sudarshan Jain
Secretary-General
Indian Pharmaceutical Alliance
Tushar Zade
CIO & CDO
Aurigene Pharmaceutical Services Limited
Umesh Mehta
EVP and Global CIO
Jubilant Life Sciences
V Simpson Emmanuel
MD and CEO
Roche India
Contact Us
-
Gaurav Vats
-
Gyanendra Singh
-
NOMINATION QUERY
Saloni Jain
-
Delegate Query
Rishi Raj Singh
-
Speaking Opportunity
Aritra Ghosh
For any urgent matters or issues requiring immediate escalation, please write to rohit.singh@financialexpress.com
